CDMO News
SK bioscience Completes L HOUSE Expansion to Boost Vaccine Production
SK bioscience, a South Korea-based vaccine and biotech company, has completed a major expansion of its L HOUSE production facility in Andong to support global supply of its 21-valent pneumococcal conjugate vaccine (PCV) candidate, GBP410. The facility has now received
2 June 2025
